GB202114656D0 - Biomarker - Google Patents

Biomarker

Info

Publication number
GB202114656D0
GB202114656D0 GBGB2114656.8A GB202114656A GB202114656D0 GB 202114656 D0 GB202114656 D0 GB 202114656D0 GB 202114656 A GB202114656 A GB 202114656A GB 202114656 D0 GB202114656 D0 GB 202114656D0
Authority
GB
United Kingdom
Prior art keywords
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2114656.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hvivo Services Ltd
Original Assignee
Hvivo Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hvivo Services Ltd filed Critical Hvivo Services Ltd
Priority to GBGB2114656.8A priority Critical patent/GB202114656D0/en
Publication of GB202114656D0 publication Critical patent/GB202114656D0/en
Priority to PCT/GB2022/052609 priority patent/WO2023062377A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
GBGB2114656.8A 2021-10-13 2021-10-13 Biomarker Ceased GB202114656D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2114656.8A GB202114656D0 (en) 2021-10-13 2021-10-13 Biomarker
PCT/GB2022/052609 WO2023062377A1 (en) 2021-10-13 2022-10-13 Methods of assessing whether a subject is at risk of developing severe symptoms of disease and/or becoming contagious after exposure, or possible exposure, to a respiratory virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2114656.8A GB202114656D0 (en) 2021-10-13 2021-10-13 Biomarker

Publications (1)

Publication Number Publication Date
GB202114656D0 true GB202114656D0 (en) 2021-11-24

Family

ID=78595142

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2114656.8A Ceased GB202114656D0 (en) 2021-10-13 2021-10-13 Biomarker

Country Status (2)

Country Link
GB (1) GB202114656D0 (en)
WO (1) WO2023062377A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201611712D0 (en) 2016-07-02 2016-08-17 Hvivo Services Ltd Methods and compounds for the treatment or prevention of severe or persistent influenza
GB201721793D0 (en) 2017-12-22 2018-02-07 Hvivo Services Ltd Methods and compunds for the treatment or prevention of hypercytokinemia and severe influenza

Also Published As

Publication number Publication date
WO2023062377A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
GB201919219D0 (en) Cancer biomarkers
GB201804648D0 (en) Combination biomarker
GB202107813D0 (en) Biomarker
GB201811093D0 (en) Biomarker
SG11202110589PA (en) Biomarkers for selinexor
GB201900677D0 (en) Biomarkers
GB202114656D0 (en) Biomarker
GB202112831D0 (en) Biomarker
GB202110365D0 (en) Biomarker
GB202014824D0 (en) Biomarker
GB202114655D0 (en) Biomarkers
GB202111201D0 (en) Biomarkers
GB202103951D0 (en) Biomarkers
GB202103140D0 (en) Biomarkers
GB202015056D0 (en) Biomarkers
GB202014190D0 (en) Biomarkers
GB202005435D0 (en) Biomarkers
GB202001361D0 (en) Biomarkers
GB201914183D0 (en) Biomarker
GB201913846D0 (en) Biomarker
GB201913612D0 (en) Biomarker
GB201912154D0 (en) Biomarker
GB201911078D0 (en) Biomarker
GB202314954D0 (en) Biomarkers
GB202216295D0 (en) Biomarkers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)